Urinary incontinence and prolapse devices market seen rising to $5.39 billion by 2030

The Business Research Company projects steady growth in the urinary incontinence and pelvic organ prolapse devices market, with demand fueled by aging populations, broader treatment access and rising interest in non-invasive care. The report also flags North America as the largest regional market in 2025 and highlights new forecasting and analysis tools in the 2026 edition.

Why it matters: - The market addresses two common conditions that affect quality of life: urinary incontinence and pelvic organ prolapse. - Demand is rising as older adults, patients and providers look for more effective, less invasive ways to manage symptoms. - The category is expanding alongside women’s health services, home care and pelvic floor rehabilitation.

What happened: - The Business Research Company released its Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Global Market Report 2026. - The report says the market will grow from $4.06 billion in 2025 to $4.28 billion in 2026. - The report forecasts the market will reach $5.39 billion by 2030. - The forecast implies a 5.4% CAGR from 2025 to 2026 and a 6.0% CAGR through 2030. - North America held the largest market share in 2025, followed by Western Europe. - The report covers Asia-Pacific, South East Asia, Eastern Europe, South America, the Middle East and Africa.

The details: - Urinary incontinence is defined in the report as involuntary urine leakage due to an overactive bladder. - Pelvic organ prolapse is described as weakness in the vaginal supporting structures. - The devices are designed to help manage symptoms, restore function and improve quality of life. - Past growth has been driven by higher incidence of urinary incontinence disorders. - Greater awareness of pelvic health issues has also supported the market. - More treatment options and wider acceptance of medical devices have added momentum. - Expansion in gynecological healthcare services has supported demand. - Looking ahead, the report points to an aging global population, stronger demand for non-invasive treatment, broader home healthcare adoption and more investment in women’s health technologies. - The report also expects growing demand for advanced pelvic floor rehabilitation devices. - Anticipated trends include wider use of minimally invasive devices, more non-surgical management, greater use of electrical stimulation therapies and more patient-centric home-use devices. - Comfort and biocompatibility are expected to become more important product priorities. - The report also notes a free sample is available here. - The full report is available here.

Between the lines: - The report’s growth story is less about one breakthrough and more about several converging demand drivers. - Aging populations remain the clearest long-term tailwind because these conditions are more common among older adults. - The shift toward non-surgical, home-based and minimally invasive care suggests buyers want easier-to-use products with lower treatment burden. - The 2026 report edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

What’s next: - The market is expected to keep growing through 2030 as demographic pressure and treatment adoption increase. - Device makers are likely to focus on less invasive, more comfortable and more home-friendly products. - Greater use of electrical stimulation and pelvic floor rehabilitation tools may shape future product development.

The bottom line: - The urinary incontinence and pelvic organ prolapse device market is moving from steady growth to broader adoption, with aging demographics and non-invasive care trends driving the next phase.